![]() |
![]() |
Your cart is empty |
||
Showing 1 - 2 of 2 matches in All Departments
While systems biology and pharmacodynamics have evolved in parallel, there are significant interrelationships that can enhance drug discovery and enable optimized therapy for each patient. Systems pharmacology is the relatively new discipline that is the interface between these two methods. This book is the first to cover the expertise from systems biology and pharmacodynamics researchers, describing how systems pharmacology may be developed and refined further to show practical applications in drug development. There is a growing awareness that pharmaceutical companies should reduce the high attrition in the pipeline due to insufficient efficacy or toxicity found in proof-of-concept and/or Phase II studies. Systems Pharmacology and Pharmacodynamics discusses the framework for integrating information obtained from understanding physiological/pathological pathways (normal body function system vs. perturbed system due to disease) and pharmacological targets in order to predict clinical efficacy and adverse events through iterations between mathematical modeling and experimentation.
While systems biology and pharmacodynamics have evolved in parallel, there are significant interrelationships that can enhance drug discovery and enable optimized therapy for each patient. Systems pharmacology is the relatively new discipline that is the interface between these two methods. This book is the first to cover the expertise from systems biology and pharmacodynamics researchers, describing how systems pharmacology may be developed and refined further to show practical applications in drug development. There is a growing awareness that pharmaceutical companies should reduce the high attrition in the pipeline due to insufficient efficacy or toxicity found in proof-of-concept and/or Phase II studies. Systems Pharmacology and Pharmacodynamics discusses the framework for integrating information obtained from understanding physiological/pathological pathways (normal body function system vs. perturbed system due to disease) and pharmacological targets in order to predict clinical efficacy and adverse events through iterations between mathematical modeling and experimentation.
|
![]() ![]() You may like...
Family Business Case Studies Across the…
Jeremy Cheng, Luis Diaz-Matajira, …
Paperback
R1,020
Discovery Miles 10 200
Research Handbook on HRM in the Public…
Bram Steijn, Eva Knies
Hardcover
R6,188
Discovery Miles 61 880
Becoming an Organizational Scholar…
Tomislav Hernaus, Matej Cerne
Hardcover
R3,207
Discovery Miles 32 070
Research Handbook on Line Managers
Keith Townsend, Anna Bos-Nehles, …
Hardcover
R6,337
Discovery Miles 63 370
Stuck - How to WIN at Work by…
Victoria Grady, Patrick McCreesh
Paperback
R935
Discovery Miles 9 350
|